Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      USAID extends $9 million loan guarantee to Healthspring

      USAID extends $9 million loan guarantee to Healthspring

      savita thakur thakur4 March 2016 11:39 AM IST
      Mumbai: To help bridge the gap in medical services, the US today extended a guarantee to loans of $9 million (Rs 60 crore) to be given to...
      Olympus to Pay at Least 646 Million dollars for giving kickbacks to doctors

      Olympus to Pay at Least 646 Million dollars for giving kickbacks to doctors

      savita thakur thakur3 March 2016 2:37 PM IST
      Olympus Corp., the nation's largest distributor of endoscopes and related equipment, will pay $646 million to resolve separate criminal and civil...
      McKesson acquires Canadian pharmacy operator Rexall

      McKesson acquires Canadian pharmacy operator Rexall

      savita thakur thakur3 March 2016 2:35 PM IST
      San Francisco: Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion,...
      Women Entrepreneurs Bring Medical Aid At Your Doorstep

      Women Entrepreneurs Bring Medical Aid At Your Doorstep

      savita thakur thakur3 March 2016 7:54 AM IST
      New Delhi: With healthcare a fast growing sector, women entrepreneurs are increasingly coming up with different services in the e-commerce...
      Philips bags clearance for Care Orchestrator ,for management of sleep and respiratory care portfolio

      Philips bags clearance for Care Orchestrator ,for management of sleep and respiratory care portfolio

      savita thakur thakur2 March 2016 5:02 PM IST
      AMSTERDAM: Philips Respironics, a business of Royal Philips , announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
      Cipla tranfers consumer healthcare biz to subsidiary

      Cipla tranfers consumer healthcare biz to subsidiary

      savita thakur thakur2 March 2016 4:50 PM IST
      New Delhi: Drug major Cipla has transferred its consumer healthcare business to its arm Cipla Health Ltd."The company's consumer healthcare business...
      NM-INBRE and NCGR to host symposium on Advances in Genome Technology

      NM-INBRE and NCGR to host symposium on Advances in Genome Technology

      savita thakur thakur2 March 2016 2:45 PM IST
      SANTA FE, N.M.: The New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE) and the National Center for Genome Resources (NCGR)...
      FDA approves new indication for Novartis drug Afinitor®  for neuroendocrine tumours

      FDA approves new indication for Novartis drug Afinitor® for neuroendocrine tumours

      savita thakur thakur1 March 2016 6:05 PM IST
      BASEL, Switzerland: Novartis today announced that the United States Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets for the...
      AstraZeneca sells drug for $70 mln as divestment drive continues

      AstraZeneca sells drug for $70 mln as divestment drive continues

      savita thakur thakur1 March 2016 5:55 PM IST
      London: AstraZeneca has sold rights to a non-core drug to a unit of Kyowa Hakko Kirin for an upfront payment of $70 million, a day after getting $500...
      FDA providing $2 million in new grants for natural history studies in rare diseases

      FDA providing $2 million in new grants for natural history studies in rare diseases

      savita thakur thakur1 March 2016 5:48 PM IST
      The U.S. Food and Drug Administration announced the availability of $2 million in research grants to fund natural history studies in rare diseases....
      Zydus Cadila gets USFDA nod for anti-diabetics tablets

      Zydus Cadila gets USFDA nod for anti-diabetics tablets

      savita thakur thakur1 March 2016 5:47 PM IST
      New Delhi: Drug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in...
      AstraZeneca cancer drug fails in mesothelioma test

      AstraZeneca cancer drug fails in mesothelioma test

      savita thakur thakur1 March 2016 5:47 PM IST
      London: A closely watched AstraZeneca drug did not extend lives of patients with the rare cancer mesothelioma when given on its own, but the drugmaker...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok